Cargando…
5‐HT (2B) receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo
Pulmonary fibrosis is characterized by excessive accumulation of connective tissue, along with activated extracellular matrix (ECM)‐producing cells, myofibroblasts. The pathological mechanisms are not well known, however serotonin (5‐HT) and 5‐HT class 2 (5‐HT (2)) receptors have been associated wit...
Autores principales: | Löfdahl, Anna, Rydell‐Törmänen, Kristina, Müller, Catharina, Martina Holst, C., Thiman, Lena, Ekström, Gunilla, Wenglén, Christina, Larsson‐Callerfelt, Anna‐Karin, Westergren‐Thorsson, Gunilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985542/ https://www.ncbi.nlm.nih.gov/pubmed/27482070 http://dx.doi.org/10.14814/phy2.12873 |
Ejemplares similares
-
Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT(2B) receptor antagonists in vitro – a potential pathway affecting proliferation
por: Löfdahl, Anna, et al.
Publicado: (2018) -
Pathological Insight into 5-HT(2B) Receptor Activation in Fibrosing Interstitial Lung Diseases
por: Löfdahl, Anna, et al.
Publicado: (2020) -
Absence of fibromodulin affects matrix composition, collagen deposition and cell turnover in healthy and fibrotic lung parenchyma
por: Rydell-Törmänen, Kristina, et al.
Publicado: (2014) -
Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts
por: Larsson-Callerfelt, Anna-Karin, et al.
Publicado: (2013) -
Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity
por: Wigén, Jenny, et al.
Publicado: (2020)